Filter
5964
Filtered Results: 5964
Text search:
drug
treatment
Featured
Recommendations
516
New Publications
1508
Language
Document type
No document type
3649
Studies & Reports
868
Guidelines
720
Manuals
249
Strategic & Response Plan
160
Fact sheets
118
Training Material
79
Situation Updates
56
Infographics
25
Brochures
16
Resource Platforms
15
Online Courses
7
App
1
Videos
1
Countries / Regions
India
367
Kenya
175
Global
168
South Africa
148
Western and Central Europe
131
Ethiopia
129
Uganda
121
Nigeria
113
Tanzania
107
Nepal
103
Liberia
91
Sierra Leone
90
Zambia
88
Malawi
87
Latin America and the Carribbean
81
Africa
78
Myanmar / Burma
74
Bangladesh
73
Ghana
72
Eastern Europe
71
Ukraine
65
Rwanda
61
Namibia
54
Philippines
49
Zimbabwe
47
Russia
45
Asia
42
Indonesia
41
Lesotho
38
Cambodia
36
South–East Asia Region
35
Mozambique
31
Botswana
30
Senegal
27
Congo, Democratic Republic of
27
Syria
25
Germany
25
Brazil
25
Eswatini/ Swaziland
23
Colombia
21
Burkina Faso
20
South Sudan
20
East and Southern Africa
18
Venezuela
17
USA
15
West and Central Africa
15
Cameroon
14
Middle East and North Africa
14
Eastern Europe and Central Asia
14
Haiti
13
Albania
12
Pakistan
12
Tajikistan
11
Guinea
11
Georgia
11
Thailand
10
China
10
Argentina
10
Afghanistan
9
Sudan
9
Peru
8
Vietnam
8
Yemen
7
North Macedonia
6
Benin
6
Armenia
6
Bolivia
6
Moldova
6
Angola
6
Mexico
5
El Salvador
5
Western Pacific Region
5
Lebanon
5
Papua New Guinea
5
Iraq
5
Somalia
5
Laos
4
Estonia
4
Guinea-Bissau
4
Jordan
4
Paraguay
4
North America
4
Jamaica
4
United Kingdom
4
Sri Lanka
4
Central African Republic
4
Libya
4
Bhutan
4
Ecuador
4
Timor Leste/ East Timor
3
Turkey
3
Iran
3
Fiji
3
Kyrgyzstan
3
Uzbekistan
3
Morocco
3
Spain
3
Palestine
3
Mali
3
Switzerland
2
Serbia
2
Kazakhstan
2
Chile
2
Canada
2
Mongolia
2
Hungary
2
Saudi Arabia
2
Portugal
2
Belarus
2
Southern Africa
2
Romania
2
Poland
2
Madagascar
2
North Korea
1
Australia
1
Gambia
1
Singapore
1
Malaysia
1
Qatar
1
Bulgaria
1
Italy
1
Lithuania
1
Ireland
1
Gabon
1
Uruguay
1
Turkmenistan
1
Denmark
1
Belgium
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Côte d’Ivoire / Ivory Coast
1
Egypt
1
Greece
1
Honduras
1
Chad
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
2244
Clinical Guidelines
548
Public Health
272
Women & Child Health
217
Key Resources
139
Capacity Building
91
Pharmacy & Technologies
57
Annual Report MEDBOX
1
Toolboxes
HIV
738
TB
680
Mental Health
635
AMR
283
NTDs
277
COVID-19
240
Pharmacy
179
NCDs
134
Caregiver
114
Ebola & Marburg
94
Rapid Response
90
Refugee
83
Conflict
63
Disability
60
Planetary Health
60
Global Health Education
48
Health Financing Toolbox
33
Polio
24
Cholera
21
Specific Hazards
19
Natural Hazards
18
Zika
16
Social Ethics
15
Malaria
5
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
Ivermectin is an antiparasitic drug approved for the treatment of parasitic infections, including strongyloidiasis and onchocerciasis in humans. There is a reported increase in the use of ivermectin for the prevention and treatment of COVID-19 by the public in African Union Member States.
Currently...
This is a detailed manual giving a step by step approach to undertaking the pharmacovigilance of antiretrovirals. It is intended to be a source of practical advice for Pharmacovigilance Centres and health professionals involved in HIV/AIDS prevention and treatment programmes. A number of WHO publica...
The pamphlet "Oxycodone" provides an overview of the opioid drug class, explaining its uses, effects, and risks. It describes positive effects like euphoria and pain relief, alongside negative effects such as respiratory depression, confusion, and constipation. Withdrawal symptoms include anxiety, i...
Protocol for the management of specialized centres for the treatment of people with alcohol and other drug abuse problems (CETAD) in the framework of the COVID-19 pandemic. Version 1.
Multidrug-resistant tuberculosis (MDR-TB) and extensively drug-resistant
tuberculosis (XDR-TB) increasingly occur in resource-constrained settings.
In the context of a national response to MDR- and XDR-TB, health workers in
TB clinics (in district hospitals and some accredited health centres) wil...
After 100 years of chemotherapy with impractical and toxic drugs, an oral cure for human African trypanosomiasis (HAT) is available: Fexinidazole. In this case, we review the history of drug discovery for HAT with special emphasis on the discovery, pre-clinical development, and operational challenge...
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
The pamphlet "What is Addiction" explains addiction as a chronic, relapsing brain disease characterized by compulsive drug seeking and use, despite harmful consequences. It highlights the dangers of different drug categories, including sedatives, stimulants, and hallucinogens, and their potential he...
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
The World Health Organization's fact sheet on opioid overdose highlights the significant global health issue posed by opioids, which include natural, semi-synthetic, and synthetic compounds used primarily for pain management. Misuse and unsupervised use can lead to dependence and severe health probl...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
Substance abuse, is a dangerous relapsing brain disease requiring intensive treatment in a professional setting. Someone who is suffering from substance abuse will have cravings and compulsive drug use that persists even in the face of negative consequences. Although substance abuse may start out as...
BMC Infectious Diseases (2019) 19:832
Intestinal schistosomiasis is highly endemic in Tanzania and mass drug administration (MDA) using
praziquantel is the mainstay of the control program. However, the MDA program covers only school aged children
and does not include neither adult individuals nor...
Chagas disease affects approximately 6 million people, mainly in Latin America. Less than 1% of affected individuals receive proper antiparasitic treatment, and current drugs are inadequate to fight the entire spectrum of the disease. Against this background, Novartis is pursuing an end-to-end appro...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
The WHO South-East Asia (SEA) Region bears a high burden of tuberculosis (TB) and MDR-TB. In 2015, the Region accounted for nearly 200 000 or 35% of the global estimated new RR/MDR-TB cases eligible for treatment. Extensively drug-resistant TB (XDRTB) has also been reported from s...
Version 10.1_5 October 2020
These Guidelines are available in different formats: As a paper booklet, a PDF, a mobile app, and now also as a website.
The 2019 version of the Guidelines introduces a new drug-drug interaction panel and now consists of six main sections, including a general overview ...
Front. Public Health 9:622809
The control and elimination of schistosomiasis have over the last two decades involved several strategies, with the current strategy by the World Health Organization (WHO) focusing mainly on treatment with praziquantel during mass drug administration (MDA). However, th...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
